Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liquid Biopsy for Detection of Driver Mutation in Diagnostic and Prognostic of NSCLC

NCT02778854 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT02778854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02778854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liquid Biopsy for Detection of Driver Mutation in Diagnostic and Prognostic of NSCLC
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2015
Completion date
November 30, 2020
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer